Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

Autor: Elisa Bonomi, Ulrich Kalinke, Stefania Gobessi, Anna Villa, Marco Catucci, Ayse Metin, Luigi D. Notarangelo, Francesca Prete, Sophie Hambleton, Maria Carmina Castiello, William Vermi, Robbert G. M. Bredius, Mayrel Labrada, Mirjam van der Burg, Federica Benvenuti, Caterina Cancrini, Alessandro Aiuti
Přispěvatelé: Immunology, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy., Prete, Francesca, Catucci, Marco, Labrada, Mayrel, Gobessi, Stefania, Castiello Maria, Carmina, Bonomi, Elisa, Aiuti, Alessandro, Vermi, William, Cancrini, Caterina, Metin, Ayse, Hambleton, Sophie, Bredius, Robbert, Notarangelo Luigi, Daniele, van der Burg, Mirjam, Kalinke, Ulrich, Villa, Anna, Benvenuti, Federica
Rok vydání: 2013
Předmět:
Male
Wiskott–Aldrich syndrome
Autoimmunity
Plasmacytoid dendritic cell
Receptor
Interferon alpha-beta

Mice
0302 clinical medicine
immune system diseases
Interferon
hemic and lymphatic diseases
Immunology and Allergy
Mice
Knockout

0303 health sciences
biology
Wiskott–Aldrich syndrome protein
hemic and immune systems
Endocytosis
Cell biology
Wiskott-Aldrich Syndrome
3. Good health
Interferon Type I
Female
Wiskott-Aldrich Syndrome Protein
medicine.drug
Signal Transduction
congenital
hereditary
and neonatal diseases and abnormalities

Immunology
macromolecular substances
Article
03 medical and health sciences
medicine
Animals
Humans
RNA
Messenger

030304 developmental biology
Innate immune system
Base Sequence
TLR9
Interferon-alpha
Dendritic Cells
Cell Biology
medicine.disease
Type I interferon production
Actins
Immunity
Innate

Mice
Inbred C57BL

Disease Models
Animal

Toll-Like Receptor 9
biology.protein
Interferon type I
030215 immunology
Zdroj: Journal of Experimental Medicine, 210(2), 355-374. Rockefeller University Press
The Journal of Experimental Medicine
ISSN: 1540-9538
0022-1007
Popis: Wiskott-Aldrich Syndrome protein (WASp)–mediated actin polymerization controls intracellular trafficking and compartmentalization of TLR9 ligands in plasmacytoid dendritic cells.
Mutations in Wiskott-Aldrich syndrome (WAS) protein (WASp), a regulator of actin dynamics in hematopoietic cells, cause WAS, an X-linked primary immunodeficiency characterized by recurrent infections and a marked predisposition to develop autoimmune disorders. The mechanisms that link actin alterations to the autoimmune phenotype are still poorly understood. We show that chronic activation of plasmacytoid dendritic cells (pDCs) and elevated type-I interferon (IFN) levels play a role in WAS autoimmunity. WAS patients display increased expression of type-I IFN genes and their inducible targets, alteration in pDCs numbers, and hyperresponsiveness to TLR9. Importantly, ablating IFN-I signaling in WASp null mice rescued chronic activation of conventional DCs, splenomegaly, and colitis. Using WASp-deficient mice, we demonstrated that WASp null pDCs are intrinsically more responsive to multimeric agonist of TLR9 and constitutively secrete type-I IFN but become progressively tolerant to further stimulation. By acute silencing of WASp and actin inhibitors, we show that WASp-mediated actin polymerization controls intracellular trafficking and compartmentalization of TLR9 ligands in pDCs restraining exaggerated activation of the TLR9–IFN-α pathway. Together, these data highlight the role of actin dynamics in pDC innate functions and imply the pDC–IFN-α axis as a player in the onset of autoimmune phenomena in WAS disease.
Databáze: OpenAIRE